Tower Research Capital LLC (Trc) Tango Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,809 shares of TNGX stock, worth $14,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,809
Previous 14,765
60.66%
Holding current value
$14,115
Previous $113,000
84.96%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TNGX
# of Institutions
137Shares Held
91.1MCall Options Held
1.4KPut Options Held
4.4K-
Trv Gp Iv, LLC Boston, MA16.9MShares$41 Million64.97% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$26.1 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$25.8 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$13.4 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$9.72 Million0.07% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $214M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...